Cargando…
The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic Review
BACKGROUND: Cell-free DNA (cfDNA) can be detected in the circulation of healthy individuals, but is found in higher concentrations in cancer patients. Furthermore, mutations in tumor cells can be identified in circulating DNA fragments. This has been the subject of significant interest in the field...
Autores principales: | Fussey, Jonathan M., Bryant, Jennifer L., Batis, Nikolaos, Spruce, Rachael J., Hartley, Andrew, Good, James S., McCabe, Christopher J., Boelaert, Kristien, Sharma, Neil, Mehanna, Hisham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937025/ https://www.ncbi.nlm.nih.gov/pubmed/29761074 http://dx.doi.org/10.3389/fonc.2018.00132 |
Ejemplares similares
-
Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
por: Payne, Karl, et al.
Publicado: (2019) -
Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors
por: Nieto, Hannah R, et al.
Publicado: (2021) -
Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma
por: Bryant, Jennifer, et al.
Publicado: (2019) -
Ultra-Low DNA Input into Whole Genome Methylation Assays and Detection of Oncogenic Methylation and Copy Number Variants in Circulating Tumour DNA
por: Whalley, Celina, et al.
Publicado: (2021) -
Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation()
por: Batis, Nikolaos, et al.
Publicado: (2021)